Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COLUMBUS 5-year update: a randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF.
Dummer R, Flaherty KT, Robert C, Arance A, B de Groot JW, Garbe C, Gogas HJ, Gutzmer R, Krajsová I, Liszkay G, Loquai C, Mandalà M, Schadendorf D, Yamazaki N, Pietro AD, Cantey-Kiser J, Edwards M, Ascierto PA. Dummer R, et al. Among authors: edwards m. Future Oncol. 2023 May;19(16):1091-1098. doi: 10.2217/fon-2022-1258. Epub 2023 Jun 13. Future Oncol. 2023. PMID: 37309702 Free article. Clinical Trial.
COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma.
Dummer R, Flaherty KT, Robert C, Arance A, de Groot JWB, Garbe C, Gogas HJ, Gutzmer R, Krajsová I, Liszkay G, Loquai C, Mandalà M, Schadendorf D, Yamazaki N, di Pietro A, Cantey-Kiser J, Edwards M, Ascierto PA. Dummer R, et al. Among authors: edwards m. J Clin Oncol. 2022 Dec 20;40(36):4178-4188. doi: 10.1200/JCO.21.02659. Epub 2022 Jul 21. J Clin Oncol. 2022. PMID: 35862871 Free PMC article. Clinical Trial.
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer.
Tabernero J, Van Cutsem E, Garralda E, Tai D, De Braud F, Geva R, van Bussel MTJ, Fiorella Dotti K, Elez E, de Miguel MJ, Litwiler K, Murphy D, Edwards M, Morris VK. Tabernero J, et al. Among authors: edwards m. Oncologist. 2023 Mar 17;28(3):230-238. doi: 10.1093/oncolo/oyad007. Oncologist. 2023. PMID: 36811382 Free PMC article. Clinical Trial.
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer.
Van Cutsem E, Yaeger R, Delord JP, Tabernero J, Siu LL, Ducreux M, Siena S, Elez E, Kasper S, Zander T, Steeghs N, Murphy D, Edwards M, Wainberg ZA. Van Cutsem E, et al. Among authors: edwards m. Oncologist. 2023 Dec 11;28(12):e1209-e1218. doi: 10.1093/oncolo/oyad210. Oncologist. 2023. PMID: 37597246 Free PMC article. Clinical Trial.
Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategy.
Goldman MP, Patel DM, Chang KZ, Davis RP, Edwards MS, Hurie JB, Sutsrim A, Velazquez-Ramirez G, Williams TK, Grandas OH, Freeman MB, McNally MM, Stevens SL, Bennett KM, Woo K, Carsten CG, Androes MP, Blas JV, Jones B, Patton RM, Parr R, Gandhi SS, York JW, Young CJ, Rabbani MU, Gardezi AI, Abdelnour LM, Lee T, Abusalah WM, Zayas CF, Hicks CW, Geetha D, Brown WM, Chen H, Allon M, Murea M; AV Access Consortium. Goldman MP, et al. Among authors: edwards ms. JVS Vasc Insights. 2024;2:100108. doi: 10.1016/j.jvsvi.2024.100108. Epub 2024 Jun 7. JVS Vasc Insights. 2024. PMID: 39802461 Free PMC article.
Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH): a pragmatic, multicentre, open-label, two-arm, individually randomised, controlled trial.
Waldron CA, Pallmann P, Schoenbuchner S, Harris D, Brookes-Howell L, Mateus C, Bernatoniene J, Cathie K, Faust SN, Hinds L, Hood K, Huang C, Jones S, Kotecha S, Nabwera HM, Patel S, Paulus SC, Powell CVE, Preston J, Xiang H, Thomas-Jones E, Carrol ED; BATCH Trial Team. Waldron CA, et al. Lancet Child Adolesc Health. 2025 Jan 8:S2352-4642(24)00306-7. doi: 10.1016/S2352-4642(24)00306-7. Online ahead of print. Lancet Child Adolesc Health. 2025. PMID: 39798581 Free article.
The Lows of High Reward: Choking Under Pressure.
Sadnicka A, Edwards MJ. Sadnicka A, et al. Among authors: edwards mj. Mov Disord. 2025 Jan 8. doi: 10.1002/mds.30092. Online ahead of print. Mov Disord. 2025. PMID: 39780499 No abstract available.
A new class of penicillin-binding protein inhibitors to address drug-resistant Neisseria gonorrhoeae.
Uehara T, Zulli AL, Miller B, Avery LM, Boyd SA, Chatwin CL, Chu GH, Drager AS, Edwards M, Emeigh Hart SG, Myers CL, Rongala G, Stevenson A, Uehara K, Yi F, Wang B, Liu Z, Wang M, Zhao Z, Zhou X, Zhao H, Stratton CM, Bala S, Davies C, Tkavc R, Jerse AE, Pevear DC, Burns CJ, Daigle DM, Condon SM. Uehara T, et al. Among authors: edwards m. bioRxiv [Preprint]. 2024 Dec 27:2024.12.27.630553. doi: 10.1101/2024.12.27.630553. bioRxiv. 2024. PMID: 39763734 Free PMC article. Preprint.
5,189 results